Patidegib

Generic Name: Patidegib

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₄₈N_₂O_₃S

CAS Number: 1037210-93-7

Unique Ingredient Identifier: JT96FPU35X

Background: Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel Technologies appoints Mori Arkin as interim CEO from Jan 1, 2025; ongoing Phase 3 trial of SGT-610 for Gorlin Syndrome with 40+ sites; SGT-210 proof-of-concept study for Darier disease continues.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy